Brain miffed by macrophage migration inhibitory factor

International Journal of Cell Biology

Volumn , Issue , 2012, Pages

  Savaskan, Nic E ^a   Fingerle Rowson, Günter ^b   Buchfelder, Michael ^a   Eyüpoglu, Ilker Y ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANGIOGENESIS; APOPTOSIS; BRAIN CANCER; CELL CYCLE REGULATION; GLYCOLYSIS; HUMAN; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84866999055     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2012/139573     Document Type: Review

References (110)

1. Isaacs A., Lindenmann J., Virus interference. I. The interferon. Proceedings of the Royal Society B 1957 147 927 258 267 10.1098/rspb.1957.0048
2. Bloom B. R., Bennett B., Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966 153 3731 80 82 2-s2.0-0013933261
3. Bloom B. R., Bennett B., Oettgen H. F., McLean E. P., Old L. J., Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration. Proceedings of the National Academy of Sciences of the United States of America 1969 64 4 1176 1180 2-s2.0-0014659108
4. David J. R., Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proceedings of the National Academy of Sciences of the United States of America 1966 56 1 72 77 2-s2.0-0013923944
5. Bernhagen J., Calandra T., Mitchell R. A., Martin S. B., Tracey K. J., Voelter W., Manogue K. R., Cerami A., Bucala R., MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993 365 6448 756 759 2-s2.0-0027442237 10.1038/365756a0 (Pubitemid 23339882)
6. Hudson J. D., Shoaibi M. A., Maestro R., Carnero A., Hannon G. J., Beach D. H., A proinflammatory cytokine inhibits p53 tumor suppressor activity. Journal of Experimental Medicine 1999 190 10 1375 1382 2-s2.0-0033571182 10.1084/jem.190.10.1375
7. Mitchell R. A., Liao H., Chesney J., Fingerle-Rowsor G., Baugh J., David J., Bucala R., Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 345 350 2-s2.0-0037039308 10.1073/pnas.012511599 (Pubitemid 34060365)
8. Morand E. F., Leech M., Bernhagen J., MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nature Reviews Drug Discovery 2006 5 5 399 410 2-s2.0-33745190762 10.1038/nrd2029 (Pubitemid 43904932)
9. Mikulowska A., Metz C. N., Bucala R., Holmdahl R., Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-lnduced arthritis in mice. Journal of Immunology 1997 158 11 5514 5517 2-s2.0-0031154718 (Pubitemid 127681261)
10. Pan J. H., Sukhova G. K., Yang J. T., Wang B., Xie T., Fu H., Zhang Y., Satoskar A. R., David J. R., Metz C. N., Bucala R., Fang K., Simon D. I., Chapman H. A., Libby P., Shi G. P., Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2004 109 25 3149 3153 2-s2.0-8344276059
11. Bifulco C., McDaniel K., Leng L., Bucala R., Tumor growth-promoting properties of macrophage migration inhibitory factor. Current Pharmaceutical Design 2008 14 36 3790 3801 2-s2.0-61449209186 10.2174/138161208786898608
12. Weiser W. Y., Temple P. A., Witek-Giannotti J. S., Remold H. G., Clark S. C., David J. R., Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proceedings of the National Academy of Sciences of the United States of America 1989 86 19 7522 7526 2-s2.0-0001052457 (Pubitemid 19254488)
13. Rosengren E., Bucala R., Åman P., Jacobsson L., Odh G., Metz C. N., Rorsman H., The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Molecular Medicine 1996 2 1 143 149 2-s2.0-0029669190
14. Kleemann R., Kapurniotu A., Frank R. W., Gessner A., Mischke R., Flieger O., Jüttner S., Brunner H., Bernhagen J., Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. Journal of Molecular Biology 1998 280 1 85 102 2-s2.0-0032479319 10.1006/jmbi.1998.1864 (Pubitemid 28312808)
15. Bendrat K., Al-Abed Y., Callaway D. J. E., Peng T., Calandra T., Metz C. N., Bucala R., Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 1997 36 49 15356 15362 2-s2.0-0030663805 10.1021/bi971153a (Pubitemid 27528002)
16. Stamps S. L., Fitzgerald M. C., Whitman C. P., Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry 1998 37 28 10195 10202 2-s2.0-0032516444 10.1021/bi9806955 (Pubitemid 28366375)
17. Esumi N., Budarf M., Ciccarelli L., Sellinger B., Kozak C. A., Wistow G., Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF. Mammalian Genome 1998 9 9 753 757 2-s2.0-0031660858 10.1007/s003359900858 (Pubitemid 28411274)
18. Swope M., Sun H. W., Blake P. R., Lolis E., Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO Journal 1998 17 13 3534 3541 2-s2.0-0032127485 10.1093/emboj/17.13.3534 (Pubitemid 28327372)
19. Paralkar V., Wistow G., Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 1994 19 1 48 51 2-s2.0-0027972744 10.1006/geno.1994.1011 (Pubitemid 24034365)
20. Pearson W. R., MIF proteins are not glutathione transferase homologs. Protein Science 1994 3 3 525 527 2-s2.0-0028329395 (Pubitemid 24103724)
21. Bernhagen J., Bacher M., Calandra T., Metz C. N., Doty S. B., Donnelly T., Bucala R., An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. Journal of Experimental Medicine 1996 183 1 277 282 2-s2.0-0030051176 10.1084/jem.183.1.277 (Pubitemid 26028767)
22. Kleemann R., Mischke R., Kapurniotu A., Brunner H., Bernhagen J., Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes. FEBS Letters 1998 430 3 191 196 2-s2.0-0032479354 10.1016/S0014-5793(98)00654-1 (Pubitemid 28337910)
23. Thiele M., Bernhagen J., Link between macrophage migration inhibitory factor and cellular redox regulation. Antioxidants and Redox Signaling 2005 7 9-10 1234 1248 2-s2.0-24144433455 10.1089/ars.2005.7.1234 (Pubitemid 41232520)
24. Herrero E., De La Torre-Ruiz M. A., Monothiol glutaredoxins: a common domain for multiple functions. Cellular and Molecular Life Sciences 2007 64 12 1518 1530 2-s2.0-34250731291 10.1007/s00018-007-6554-8 (Pubitemid 46954154)
25. Meng E. C., Babbitt P. C., Topological variation in the evolution of new reactions in functionally diverse enzyme superfamilies. Current Opinion in Structural Biology 2011 21 3 391 397 2-s2.0-79958023248 10.1016/j.sbi.2011.03. 007
26. 2 incorporation by a heme-containing dioxygenase. Proceedings of the National Academy of Sciences of the United States of America 2006 103 8 2611 2616 2-s2.0-33644511372 10.1073/pnas.0508996103
27. Sun H. W., Bernhagen J., Bucala R., Lolis E., Crystal structure at 2.6-Å resolution of human macrophage migration inhibitory factor. Proceedings of the National Academy of Sciences of the United States of America 1996 93 11 5191 5196 2-s2.0-0029895838
28. Suzuki M., Sugimoto H., Nakagawa A., Tanaka I., Nishihira J., Sakai M., Crystal structure of the macrophage migration inhibitory factor from rat liver. Nature Structural Biology 1996 3 3 259 266 2-s2.0-0029971584 10.1038/nsb0396-259 (Pubitemid 26081709)
29. Takahashi M., Nishihira J., Shimpo M., Mizue Y., Ueno S., Mano H., Kobayashi E., Ikeda U., Shimada K., Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovascular Research 2001 52 3 438 445 2-s2.0-0035217023 10.1016/S0008-6363(01)00408-4 (Pubitemid 33153106)
30. Nguyen M. T., Beck J., Lue H., Fünfzig H., Kleemann R., Koolwijk P., Kapurniotu A., Bernhagen J., A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(5065), exhibits redox activity and has MIF-like biological functions. Journal of Biological Chemistry 2003 278 36 33654 33671 2-s2.0-0141446025 10.1074/jbc.M301735200 (Pubitemid 37553198)
31. Tuyet Nguyen M., Lue H., Kleemann R., Thiele M., Tolle G., Finkelmeier D., Wagner E., Braun A., Bernhagen J., The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. Journal of Immunology 2003 170 6 3337 3347 2-s2.0-0347927255 (Pubitemid 36302213)
32. Ceccarelli J., Delfino L., Zappia E., Castellani P., Borghi M., Ferrini S., Tosetti F., Rubartelli A., The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants. International Journal of Cancer 2008 123 8 1770 1778 2-s2.0-51949087589 10.1002/ijc.23709
33. Harrison R. A., Sumners C., Redox regulation of macrophage migration inhibitory factor expression in rat neurons. Biochemical and Biophysical Research Communications 2009 390 1 171 175 2-s2.0-70349939460 10.1016/j.bbrc.2009.09.112
34. Koga K., Kenessey A., Powell S. R., Sison C. P., Miller E. J., Ojamaa K., Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxidants and Redox Signaling 2011 14 7 1191 1202 2-s2.0-79952369026 10.1089/ars.2010.3163
35. Busche S., Gallinat S., Fleegal M. A., Raizada M. K., Sumners C., Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. Endocrinology 2001 142 11 4623 4630 2-s2.0-0034750592 10.1210/en.142.11.4623 (Pubitemid 33022337)
36. Sun C., Li H., Leng L., Raizada M. K., Bucala R., Sumners C., Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. Journal of Neuroscience 2004 24 44 9944 9952 2-s2.0-7744235386 10.1523/JNEUROSCI.2856-04.2004 (Pubitemid 39463575)
37. Su A. I., Wiltshire T., Batalov S., Lapp H., Ching K. A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M. P., Walker J. R., Hogenesch J. B., A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences of the United States of America 2004 101 16 6062 6067 2-s2.0-11144358198 10.1073/pnas.0400782101 (Pubitemid 38520528)
38. Wu C., Orozco C., Boyer J., Leglise M., Goodale J., Batalov S., Hodge C. L., Haase J., Janes J., Huss J. W., Su A. I., BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biology 2009 10 11, article R130 2-s2.0-76249090489 10.1186/gb-2009-10- 11-r130
39. Lein E. S., Hawrylycz M. J., Ao N., Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007 445 7124 168 176 10.1038/nature05453 (Pubitemid 46095716)
40. Koong A. C., Denko N. C., Hudson K. M., Schindler C., Swiersz L., Koch C., Evans S., Ibrahim H., Le Q. T., Terris D. J., Giaccia A. J., Candidate genes for the hypoxic tumor phenotype. Cancer Research 2000 60 4 883 887 2-s2.0-0034652779 (Pubitemid 30129520)
41. Bacher M., Schrader J., Thompson N., Kuschela K., Gemsa D., Waeber G., Schlegel J., Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. American Journal of Pathology 2003 162 1 11 17 2-s2.0-0037223573 (Pubitemid 36041985)
42. Winner M., Koong A. C., Rendon B. E., Zundel W., Mitchell R. A., Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Research 2007 67 1 186 193 2-s2.0-33846435328 10.1158/0008-5472.CAN-06-3292 (Pubitemid 46142774)
43. Dumitru C. A., Gholaman H., Trellakis S., Bruderek K., Dominas N., Gu X., Bankfalvi A., Whiteside T. L., Lang S., Brandau S., Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. International Journal of Cancer 2011 129 4 859 869 2-s2.0-79959747574 10.1002/ijc.25991
44. Welford S. M., Bedogni B., Gradin K., Poellinger L., Powell M. B., Giaccia A. J., HIF1 α delays premature senescence through the activation of MIF. Genes and Development 2006 20 24 3366 3371 2-s2.0-33845710642 10.1101/gad.1471106 (Pubitemid 44969155)
45. Oda S., Oda T., Nishi K., Takabuchi S., Wakamatsu T., Tanaka T., Adachi T., Fukuda K., Semenza G. L., Hirota K., Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE 2008 3 5 2-s2.0-48249137727 10.1371/journal.pone.0002215 e2215
46. Iwata S., Hori T., Sato N., Hirota K., Sasada T., Mitsui A., Hirakawa T., Yodoi J., Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. Journal of Immunology 1997 158 7 3108 3117 2-s2.0-0031114040 (Pubitemid 127484023)
47. Talos F., Mena P., Fingerle-Rowson G., Moll U., Petrenko O., MIF loss impairs Myc-induced lymphomagenesis. Cell Death and Differentiation 2005 12 10 1319 1328 2-s2.0-27144516430 10.1038/sj.cdd.4401653 (Pubitemid 41486102)
48. Xiao D. Z., Dai B., Chen J., Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells. Cell Proliferation 2011 44 6 582 590 10.1111/j.1365-2184.2011.00787.x
49. Xu X., Wang B., Ye C., Yao C., Lin Y., Huang X., Zhang Y., Wang S., Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Letters 2008 261 2 147 157 2-s2.0-39149090701 10.1016/j.canlet.2007.11.028 (Pubitemid 351253721)
50. Liao B., Zhong B. L., Li Z., Tian X. Y., Li Y., Li B., Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. Journal of Surgical Oncology 2010 102 7 844 851 2-s2.0-78649644727 10.1002/jso.21728
51. Veillat V., Carli C., Metz C. N., Al-Abed Y., Naccache P. H., Akoum A., Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. Journal of Clinical Endocrinology and Metabolism 2010 95 12 E403 E412 2-s2.0-78650046206 10.1210/jc.2010-0417
52. Sugimoto H., Suzuki M., Nakagawa A., Tanaka I., Nishihira J., Crystal structure of macrophage migration inhibitory factor from human lymphocyte at 2.1 Å resolution. FEBS Letters 1996 389 2 145 148 2-s2.0-0030199879 10.1016/0014-5793(96)00553-4 (Pubitemid 26226488)
53. Sugimoto H., Taniguchi M., Nakagawa A., Tanaka I., Suzuki M., Nishihira J., Crystallization and preliminary X-ray analysis of human D-dopachrome tautomerase. Journal of Structural Biology 1997 120 1 105 108 2-s2.0-0031257725 10.1006/jsbi.1997.3904 (Pubitemid 27486314)
54. Taylor A. B., Johnson W. H., Czerwinski R. M., Li H. S., Hackert M. L., Whitman C. P., Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 Å resolution: implications for enzymatic catalysis and inhibition. Biochemistry 1999 38 23 7444 7452 2-s2.0-0033535983 10.1021/bi9904048 (Pubitemid 29270164)
55. Lubetsky J. B., Swope M., Dealwis C., Blake P., Lolis E., Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry 1999 38 22 7346 7354 2-s2.0-0033153283 10.1021/bi990306m (Pubitemid 29262796)
56. Hermanowski-Vosatka A., Mundt S. S., Ayala J. M., Goyal S., Hanlon W. A., Czerwinski R. M., Wright S. D., Whitman C. P., Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 1999 38 39 12841 12849 2-s2.0-0033613089 10.1021/bi991352p (Pubitemid 29463280)
57. Fingerle-Rowson G., Kaleswarapu D. R., Schlander C., Kabgani N., Brocks T., Reinart N., Busch R., Schütz A., Lue H., Du X., Liu A., Xiong H., Chen Y., Nemajerova A., Hallek M., Bernhagen J., Leng L., Bucala R., A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Molecular and Cellular Biology 2009 29 7 1922 1932 2-s2.0-63049135766 10.1128/MCB.01907-08
58. Rendon B. E., Willer S. S., Zundel W., Mitchell R. A., Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation. Experimental and Molecular Pathology 2009 86 3 180 185 2-s2.0-67349205144 10.1016/j.yexmp.2009.01.001
59. Fingerle-Rowson G., Petrenko O., Metz C. N., Forsthuber T. G., Mitchell R., Huss R., Moll U., Müller W., Bucala R., The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9354 9359 2-s2.0-0042424664 10.1073/pnas.1533295100 (Pubitemid 37033932)
60. Bozza M., Satoskar A. R., Lin G., Lu B., Humbles A. A., Gerard C., David J. R., Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. Journal of Experimental Medicine 1999 189 2 341 346 2-s2.0-0033579884 10.1084/jem.189.2.341 (Pubitemid 29063255)
61. Honma N., Koseki H., Akasaka T., Nakayama T., Taniguchi M., Serizawa I., Akahori H., Osawa M., Mikayama T., Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 2000 100 1 84 90 2-s2.0-0242445578 10.1046/j.1365-2567.2000.00011.x (Pubitemid 30242886)
62. Chagnon F., Metz C. N., Bucala R., Lesur O., Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circulation Research 2005 96 10 1095 1102 2-s2.0-20344397715 10.1161/01.RES.0000168327.22888.4d (Pubitemid 40791382)
63. Bernhagen J., Krohn R., Lue H., Gregory J. L., Zernecke A., Koenen R. R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S. R., Bucala R., Hickey M. J., Weber C., MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine 2007 13 5 587 596 2-s2.0-34249066942 10.1038/nm1567 (Pubitemid 46828480)
64. Gore Y., Starlets D., Maharshak N., Becker-Herman S., Kaneyuki U., Leng L., Bucala R., Shachar I., Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. Journal of Biological Chemistry 2008 283 5 2784 2792 2-s2.0-40949087882 10.1074/jbc.M703265200
65. Merk M., Zierow S., Leng L., The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proceedings of the National Academy of Sciences of the United States of America 2011 108 34 577 585 10.1073/pnas.1102941108
66. Calandra T., Spiegel L. A., Metz C. N., Bucala R., Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proceedings of the National Academy of Sciences of the United States of America 1998 95 19 11383 11388 2-s2.0-0032530821 10.1073/pnas.95.19.11383 (Pubitemid 28450137)
67. McDevitt M. A., Xie J., Shanmugasundaram G., Griffith J., Liu A., McDonald C., Thuma P., Gordeuk V. R., Metz C. N., Mitchell R., Keefer J., David J., Leng L., Bucala R., A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. Journal of Experimental Medicine 2006 203 5 1185 1196 2-s2.0-33646691749 10.1084/jem.20052398 (Pubitemid 43736589)
68. Arjona A., Foellmer H. G., Town T., Leng L., McDonald C., Wang T., Wong S. J., Montgomery R. R., Fikrig E., Bucala R., Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. Journal of Clinical Investigation 2007 117 10 3059 3066 2-s2.0-34948860191 10.1172/JCI32218 (Pubitemid 47529635)
69. Bacher M., Meinhardt A., Lan H. Y., Dhabhar F. S., Mu W., Metz C. N., Chesney J. A., Gemsa D., Donnelly T., Atkins R. C., Bucala R., MIF expression in the rat brain: implications for neuronal function. Molecular Medicine 1998 4 4 217 230 2-s2.0-7344230483 (Pubitemid 28331239)
70. Schwarz S. C., Schwarz J., Sautter J., Oertel W. H., Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminegic grafts in the 6-hydroxydopamine rat model of Parkinson's disease. Experimental Brain Research 1998 120 1 95 103 2-s2.0-0031920247 10.1007/s002210050381 (Pubitemid 28212023)
71. Ohta S., Misawa A., Fukaya R., Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells. Journal of Cell Science. In press
72. Bacher M., Deuster O., Aljabari B., Egensperger R., Neff F., Jessen F., Popp J., Noelker C., Reese J. P., Al-Abed Y., Dodel R., The role of macrophage migration inhibitory factor in alzheimer's disease. Molecular Medicine 2010 16 3-4 116 121 2-s2.0-77649131948 10.2119/molmed.2009.00123
73. Calandra T., Bernhagen J., Mitchell R. A., Bucala R., The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. Journal of Experimental Medicine 1994 179 6 1895 1902 2-s2.0-0028305693 10.1084/jem.179.6.1895 (Pubitemid 24155670)
74. Leng L., Metz C. N., Fang Y., Xu J., Donnelly S., Baugh J., Delohery T., Chen Y., Mitchell R. A., Bucala R., MIF signal transduction initiated by binding to CD74. Journal of Experimental Medicine 2003 197 11 1467 1476 2-s2.0-12444285441 10.1084/jem.20030286 (Pubitemid 36686708)
75. Calandra T., Roger T., Macrophage migration inhibitory factor: a regulator of innate immunity. Nature Reviews Immunology 2003 3 10 791 800 2-s2.0-0142259734 (Pubitemid 37328657)
76. Shi X., Leng L., Wang T., Wang W., Du X., Li J., McDonald C., Chen Z., Murphy J. W., Lolis E., Noble P., Knudson W., Bucala R., CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006 25 4 595 606 2-s2.0-33749508911 10.1016/j.immuni.2006.08.020 (Pubitemid 44529040)
77. Leng L., Bucala R., Insight into the biology of Macrophage Migration Inhibitory Factor (MIF) revealed by the cloning of its cell surface receptor. Cell Research 2006 16 2 162 168 2-s2.0-32644454746 10.1038/sj.cr.7310022 (Pubitemid 43247972)
78. Balachandran S., Rodge A., Gadekar P. K., Yadav V. N., Kamath D., Chetrapal-Kunwar A., Bhatt P., Srinivasan S., Sharma S., Vishwakarma R. A., Dagia N. M., Novel derivatives of ISO-1 as potent inhibitors of MIF biological function. Bioorganic and Medicinal Chemistry Letters 2009 19 16 4773 4776 2-s2.0-67749099598 10.1016/j.bmcl.2009.06.052
79. Jorgensen W. L., Gandavadi S., Du X., Hare A. A., Trofimov A., Leng L., Bucala R., Receptor agonists of macrophage migration inhibitory factor. Bioorganic and Medicinal Chemistry Letters 2010 20 23 7033 7036 2-s2.0-78149279659 10.1016/j.bmcl.2010.09.118
80. Schwartz V., Lue H., Kraemer S., Korbiel J., Krohn R., Ohl K., Bucala R., Weber C., Bernhagen J., A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Letters 2009 583 17 2749 2757 2-s2.0-69249228563 10.1016/j.febslet.2009.07.058
81. Weber C., Kraemer S., Drechsler M., Lue H., Koenen R. R., Kapurniotu A., Zernecke A., Bernhagen J., Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment. Proceedings of the National Academy of Sciences of the United States of America 2008 105 42 16278 16283 2-s2.0-55849139457 10.1073/pnas.0804017105
82. Onodera S., Suzuki K., Matsuno T., Kaneda K., Takagi M., Nishihira J., Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 1997 92 1 131 137 2-s2.0-0030796319 (Pubitemid 27380892)
83. Bacher M., Metz C. N., Calandra T., Mayer K., Chesney J., Lohoff M., Gemsa D., Donnelly T., Bucala R., An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7849 7854 2-s2.0-0029845783 10.1073/pnas.93.15.7849 (Pubitemid 26277127)
84. Calandra T., Bernhagen J., Metz C. N., Spiegel L. A., Bacher M., Donnelly T., Cerami A., Bucala R., MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995 377 6544 68 71 2-s2.0-0029143676 10.1038/377068a0
85. Donnelly S. C., Haslett C., Reid P. T., Grant I. S., Wallace W. A. H., Metz C. N., Bruce L. J., Bucala R., Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nature Medicine 1997 3 3 320 323 2-s2.0-0031052013 10.1038/nm0397-320 (Pubitemid 27112930)
86. Roger T., Chanson A. L., Knaup-Reymond M., Calandra T., Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. European Journal of Immunology 2005 35 12 3405 3413 2-s2.0-29744463898 10.1002/eji.200535413 (Pubitemid 43025521)
87. Daun J. M., Cannon J. G., Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic I κ B α American Journal of Physiology 2000 279 3 R1043 R1049 2-s2.0-0033833595
88. Löwenberg M., Stahn C., Hommes D. W., Buttgereit F., Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 2008 73 9-10 1025 1029 2-s2.0-44549088412 10.1016/j.steroids.2007.12.002
89. Piette C., Munaut C., Foidart J. M., Deprez M., Treating gliomas with glucocorticoids: from bedside to bench. Acta Neuropathologica 2006 112 6 651 664 2-s2.0-33750343080 10.1007/s00401-006-0100-x (Pubitemid 44615026)
90. Aeberli D., Yang Y., Mansell A., Santos L., Leech M., Morand E. F., Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Letters 2006 580 3 974 981 2-s2.0-31444433354 10.1016/j.febslet. 2006.01.027 (Pubitemid 43152322)
91. Santos L., Hall P., Metz C., Bucala R., Morand E. F., Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clinical and Experimental Immunology 2001 123 2 309 314 2-s2.0-0035118098 10.1046/j.1365-2249.2001.01423.x (Pubitemid 32174784)
92. Benigni F., Atsumi T., Calandra T., Metz C., Echtenacher B., Peng T., Bucala R., The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. Journal of Clinical Investigation 2000 106 10 1291 1300 2-s2.0-0033677088
93. Miller E. J., Li J., Leng L., McDonald C., Atsumi T., Bucala R., Young L. H., Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 2008 451 7178 578 582 2-s2.0-38749137749 10.1038/nature06504 (Pubitemid 351186266)
94. Mitchell R. A., Metz C. N., Peng T., Bucala R., Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. Journal of Biological Chemistry 1999 274 25 18100 18106 2-s2.0-0033580992 10.1074/jbc.274.25.18100 (Pubitemid 29283341)
95. Kleemann R., Hausser A., Geiger G., Mischke R., Burger-Kentischer A., Flieger O., Johannes F. J., Roger T., Calandra T., Kapurniotu A., Grell M., Finkelmeier D., Brunner H., Bernhagen J., Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000 408 6809 211 216 2-s2.0-0034626730 10.1038/35041591
96. Nemajerova A., Mena P., Fingerle-Rowson G., Moll U. M., Petrenko O., Impaired DNA damage checkpoint response in MIF-deficient mice. EMBO Journal 2007 26 4 987 997 2-s2.0-33847222121 10.1038/sj.emboj.7601564
97. Nemajerova A., Moll U. M., Petrenko O., Fingerle-Rowson G., Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle. Cell Cycle 2007 6 9 1030 1034 2-s2.0-34248175178 (Pubitemid 46708574)
98. Schulz R., Marchenko N. D., Holembowski L., Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression. The Journal of Experimental Medicine 2012 209 2 275 289 10.1084/jem.20111117
99. Fingerle-Rowson G. R., Bucala R., Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunology and Cell Biology 2001 79 4 368 375 2-s2.0-0034884287 10.1046/j.1440-1711.2001.01024.x (Pubitemid 32746966)
100. Mittelbronn M., Platten M., Zeiner P., Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression. Acta Neuropathologica 2011 122 3 353 365 10.1007/s00401-011-0858-3
101. Engelhorn T., Savaskan N. E., Schwarz M. A., Kreutzer J., Meyer E. P., Hahnen E., Ganslandt O., Dörfler A., Nimsky C., Buchfelder M., Eyüpoglu I. Y., Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Science 2009 100 10 1856 1862 2-s2.0-70349603638 10.1111/j.1349-7006.2009.01259.x
102. Savaskan N. E., Heckel A., Hahnen E., Engelhorn T., Doerfler A., Ganslandt O., Nimsky C., Buchfelder M., Eyüpoglu I. Y., Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nature Medicine 2008 14 6 629 632 2-s2.0-44949122670 10.1038/nm1772 (Pubitemid 351809547)
103. Savaskan N. E., Eyüpoglu I. Y., XCT modulation in gliomas: relevance to energy metabolism and tumor microenvironment normalization. Annals of Anatomy 2010 192 5 309 313 2-s2.0-77956615063 10.1016/j.aanat.2010.07.003
104. Ullrich O., Diestel A., Eyüpoglu I. Y., Nitsch R., Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nature Cell Biology 2001 3 12 1035 1042 2-s2.0-0035202873 10.1038/ncb1201-1035 (Pubitemid 33130453)
105. - and thereby promotes tumor growth. Cancer Cell 2011 19 3 387 400 2-s2.0-79952528125 10.1016/j.ccr.2011.01.038
106. Santos L. L., Dacumos A., Yamana J., Sharma L., Morand E. F., Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clinical and Experimental Immunology 2008 152 2 372 380 2-s2.0-42149102072 10.1111/j.1365-2249.2008.03639. x (Pubitemid 351522760)
107. Hoi A. Y., Hickey M. J., Hall P., Yamana J., O'Sullivan K. M., Santos L. L., James W. G., Kitching A. R., Morand E. F., Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice. Journal of Immunology 2006 177 8 5687 5696 2-s2.0-33749509030 (Pubitemid 44527645)
108. Leng L., Chen L., Fan J., Greven D., Arjona A., Du X., Austin D., Kashgarian M., Yin Z., Huang X. R., Lan H. Y., Lolis E., Nikolic-Paterson D., Bucala R., A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr mice. Journal of Immunology 2011 186 1 527 538 2-s2.0-79251539843 10.4049/jimmunol. 1001767
109. Wang X. B., Tian X. Y., Li Y., Li B., Li Z., Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. Journal of Neuro-Oncology 2012 106 1 43 51 2-s2.0-79959659713 10.1007/s11060-011-0640-3
110. Kitange G. J., Carlson B. L., Schroeder M. A., Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance. Journal of Neuro-Oncology 2010 100 2 177 186 10.1007/s11060-010-0186-9